GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » PKU Healthcare Corp Ltd (SZSE:000788) » Definitions » EV-to-EBITDA

PKU Healthcare (SZSE:000788) EV-to-EBITDA : 24.49 (As of Jun. 23, 2024)


View and export this data going back to 1997. Start your Free Trial

What is PKU Healthcare EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, PKU Healthcare's enterprise value is ¥2,748 Mil. PKU Healthcare's EBITDA for the trailing twelve months (TTM) ended in Mar. 2024 was ¥112 Mil. Therefore, PKU Healthcare's EV-to-EBITDA for today is 24.49.

The historical rank and industry rank for PKU Healthcare's EV-to-EBITDA or its related term are showing as below:

SZSE:000788' s EV-to-EBITDA Range Over the Past 10 Years
Min: -293.94   Med: 49.52   Max: 225.16
Current: 24.49

During the past 13 years, the highest EV-to-EBITDA of PKU Healthcare was 225.16. The lowest was -293.94. And the median was 49.52.

SZSE:000788's EV-to-EBITDA is ranked worse than
74.58% of 708 companies
in the Drug Manufacturers industry
Industry Median: 14.185 vs SZSE:000788: 24.49

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-06-23), PKU Healthcare's stock price is ¥5.07. PKU Healthcare's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 was ¥0.120. Therefore, PKU Healthcare's PE Ratio for today is 42.25.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.


PKU Healthcare EV-to-EBITDA Historical Data

The historical data trend for PKU Healthcare's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PKU Healthcare EV-to-EBITDA Chart

PKU Healthcare Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-EBITDA
Get a 7-Day Free Trial Premium Member Only Premium Member Only 37.76 40.30 31.16 29.09 27.37

PKU Healthcare Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EV-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 43.73 41.06 44.37 27.37 26.44

Competitive Comparison of PKU Healthcare's EV-to-EBITDA

For the Drug Manufacturers - Specialty & Generic subindustry, PKU Healthcare's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


PKU Healthcare's EV-to-EBITDA Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, PKU Healthcare's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where PKU Healthcare's EV-to-EBITDA falls into.



PKU Healthcare EV-to-EBITDA Calculation

PKU Healthcare's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=2748.451/112.25
=24.49

PKU Healthcare's current Enterprise Value is ¥2,748 Mil.
PKU Healthcare's EBITDA for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥112 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


PKU Healthcare  (SZSE:000788) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

PKU Healthcare's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=5.07/0.120
=42.25

PKU Healthcare's share price for today is ¥5.07.
PKU Healthcare's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥0.120.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?


PKU Healthcare EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of PKU Healthcare's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


PKU Healthcare (SZSE:000788) Business Description

Traded in Other Exchanges
N/A
Address
Zhongguancun Rd 298 Founder Building, 7th floor, Haidian District, Beijing, CHN, 100871
PKU Healthcare Corp Ltd is the industrial-academic-research platform of Peking University Health Science Center. The company operates in the pharmaceutical industry. It manufactures and distributes pharmaceutical products.
Executives
He Qing Kai Executives
Xu Wei Yu Supervisors
Liu Deng Han Executives
Li Bin Supervisors
Huang Cheng Supervisors
Zhang Xiao Ping Supervisors
Gao Jian Jun Executives

PKU Healthcare (SZSE:000788) Headlines

No Headlines